F. Giangaspero, C. G. Eberhart, H. Haapasalo, T. Pietsch, O. D. Wiestler and D. W. Ellison, “WHO Classification of Tumors of Central Nervous System,” In: D. N. Louis, H. Ohgaki, O. D. Wiestler and W. K. Cavenee, Eds., IARC Press, Lyon, 2007, pp. 132-140.
 A. Gajjar, M. Chintagumpala, D. Ashley, et al., “Risk- adapted Craniospinal Radiotherapy Followed by High- Dose Chemotherapy and Stem-Cell Rescue in Children with Newly Diagnosed Medulloblastoma (St Jude Medulloblastoma-96): Long-Term Results from a Prospective, Multicentre Trial,” Lancet Oncology, Vol. 7, 2006, pp. 813-820.
 A. Peyrl, K. Krapfenbauer, I. Slavc, et al., “Protein Profiles of Medulloblastoma Cell Lines DAOY and D283: Identification of Tumor-Related Proteins and Principles,” Proteomics, Vol. 3, 2003, pp. 1781-1800.
 G. Barbero, F. Carta, G. Giribaldi, et al., “Protein/RNA Coextraction and Small Twodimensional Polyacrylamide Gel Electrophoresis for Proteomic/Gene Expression Analysis of Renal Cancer Biopsies,” Analytical Biochemistry, Vol. 349, 2006, pp. 62-71.
 F. Carta, P. P. Demuro, C. Zanini, et al., “Analysis of Candidate Genes through a Proteomicsbased Approach in Primary Cell Lines from Malignant Melanomas and their Metastases,” Melanoma Research, Vol. 15, 2005, pp. 235-244.
 M. Mojsin, M. Stevanovic, “PBX1 and MEIS 1 Up-regulate SOX3gene Expression by Direct Iteraction with a Consensus Binding Site within the Basal Promoter Region,” Biochemical Journal, Vol. 425, 2009, pp. 107- 116.
 C. Zanini, G. Giribaldi, G. Mandili, et al., “Inhibition of Heat Shock Proteins (HSP) Expression by Quercetin and Differential Doxorubicin Sensitization in Neuroblastoma and Ewing’s Sarcoma Cell Lines,” Journal of Neurochemistry, Vol. 103, 2007, pp. 1344-1354.
 Y. J. Qi, Q. Y. He, Y. F. Ma, et al., “Proteomic Identification of Malignant Transformation-Related Proteins in Esophageal Squamous Cell Carcinoma,” Journal of Cellular Biochemistry, Vol. 104, 2008, pp. 625-635.
 B. B. Ma, R. G. Bristow, J. Kim, L. L. Siu, “Combined modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents,” Journal of Clinical Oncology, Vol. 21, 2003, pp. 2760-2776.
 L. Smith, O. Qutob, M. B. Watson, et al., “Proteomic Identification of Putative Biomarkers of Radiotherapy Resistence: A Possible Role of the 26S Proteasome?” Neoplasia, Vol. 11, 2009, pp. 1194-1207.
 D. Hambardzumyan, O. J. Becher, M. K. Rosenblum, et al., “PI3K Pathway Regulates Survival of Cancer Stem Cells Residing in the Perivascular Niche Following Radiation in Medulloblastoma in Vivo,” Genes, Vol. 22, 2008, pp. 436-448.
 C. S. McManamy, J. Pears, C. L. Weston, et al., “Nodule Formation and Desmoplasia in Medulloblastomas- Defining the Nodular/Desmoplastic Variant and its Biological Behavior,” Brain Pathology, Vol. 17, 2007, pp. 151-164.